More IBM OEM deals7 Jan 2025 16:34
Great post from Pearls
I think many are misunderstanding the liquidity levels at CRTA. In the third quarter update, SK advised that:
"- On track to achieve $20m annualised cost run rate as we exit FY24
· Cash position of $12.9m as at 30 September 2024
Guidance retained for FY24 bookings at $13-$15m, YTD $4.1m
Bookings in Q3 2024 were $1.7m (Q3 2023: $1.7m), with the business mix driven by DI growth, accounting for 82% of bookings and DevOps software accounting for 18% of bookings.
the remaining $1.7m of the prepay has been retired early."
Meanwhile in December, SK said:
"Cash overheads run rate is currently c.$5m for Q4, slightly better than expectations. Cash burn for Q4 will be dependent on the closing bookings and cash collection for the quarter once complete. It is anticipated that Q4FY24 cash burn will show sequential improvement relative to Q3FY24 (Q3FY24: c. $3.2m).
We inherited a broken business from a peak annualized cost base of $45m per annum to a company exiting FY24 with a cash overhead of circa $20m per annum. Our cash burn in Q1FY23 was an unsustainable $11m per quarter and as we exit Q4, Cirata will be on a path towards cash flow breakeven.
The Data Integration product performance has improved from -87% decline in Q1FY23 to 180% growth in the last reported quarter, Q3FY24."
In combination, I believe the following will be advised in January's update:
cash burn for Q4 2024 will come in under $2m, after all the number of employees is sharply down now [just 92 for the last quarter]. There is also the misunderstood $1.7m prepay to consider. IBM are now paying for each contract, there is no prepay anymore. In Q3 they did 8 contracts, I believe they may have concluded 14 - 18 in Q4 as it is their busiest month. The issue though is that there's always slippage, and SK advised on this so I think annual FY 2024 bookings will come in around $12m - I don't expect it to be far off the lower end, but a number of contracts are signing into 2025 for costing and accounting purposes. Forward looking, I expect SK to confirm that whilst 2024 ended at a cash flow break even level, from Q1 2025, growth is beckoning, with increased orders being signed, numerous DI deals being struck like the IBM one, and a cost base of around $20m to $17m.
CRTA are uniquely positioned in the field, this I expect them to demonstrate as the their reputation continues to come back and big buyers reconnect and start using them again. It's just waiting now for a dynamic revaluation once SK advises the FY2024 details.